Anti-GAD1 (GAD67) monoclonal Antibody | MB62253

Anti-GAD1 (GAD67) monoclonal Antibody | MB62253 | Gentaur UK, US & Europe Distribution

Host: Mouse

Reactivity: Human, Mouse, Rat

Application: IHC, IP, WB

Application Range: WB: 1:200 - 1:1000, IHC: 1:50, IP: 4ug/mL

Background: This gene encodes one of several forms of glutamic acid decarboxylase, identified as a major autoantigen in insulin-dependent diabetes. The enzyme encoded is responsible for catalyzing the production of gamma-aminobutyric acid from L-glutamic acid. A pathogenic role for this enzyme has been identified in the human pancreas since it has been identified as an autoantigen and an autoreactive T cell target in insulin-dependent diabetes. This gene may also play a role in the stiff man syndrome. Deficiency in this enzyme has been shown to lead to pyridoxine dependency with seizures. Alternative splicing of this gene results in two products, the predominant 67-kD form and a less-frequent 25-kD form.

Storage & Stability: PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.

Specificity: glutamate decarboxylase 1

Molecular Weight: 66.9 kDa (Predicted)

Note: For research use only, not for use in diagnostic procedure.

Alternative Names: CPSQ1; GAD; SCP

Immunogen: Full-length protein expressed in 293T cell transfected with human GAD1 expression vector

Conjugate: Unconjugated

Modification: Unmodification

Purification & Purity: Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G)

Pathway: N/A